Comerica Bank’s IO Biotech IOBT Stock Holding History

Comerica Bank’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$4	–	3788
2023 Q4	$4	Buy	+2	New	+$2	﹤0.01%	3727

Other funds holding IOBT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Comerica Bank's IOBT Position: Q1 2024 in Review

Comerica Bank sold out of IO Biotech (IOBT) in Q1 2024, closing a stake of 2 shares — an estimated $4 sold.

Comerica Bank first reported a position in IOBT in Q4 2023 and held it in 1 quarter. The position peaked at $4 in Q4 2023. 18 funds tracked by Wall St. Rank hold IOBT as of Q1 2024.

Comerica Bank reported no remaining IO Biotech position as of Q1 2024 after selling out during the quarter.
Comerica Bank sold 2 IO Biotech shares in Q1 2024, an estimated $4.
Comerica Bank first reported a position in IO Biotech in Q4 2023 and held it in 1 quarter.
Comerica Bank's IO Biotech position peaked at $4 in Q4 2023.
18 funds tracked by Wall St. Rank held IO Biotech as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.